Lessler J, Rodriguez-Barraquer I, Cummings DA, Garske T, Van Kerkhove M, Mills H, Truelove S, Hakeem R, Albarrak A, Ferguson NM; MERS-CoV Scenario Modeling Working Group; MERS-CoV Scenario Modeling Working Group.

Estimating Potential Incidence of MERS-CoV Associated with Hajj Pilgrims to Saudi Arabia, 2014.

PLoS Curr, 2014; 6: . 10.1371/currents.outbreaks.c5c9c9abd636164a9b6fd4dbda974369
Eshleman SH, Hughes JP, Laeyendecker O, Wang J, Brookmeyer R, Johnson-Lewis L, Mullis CE, Hackett J Jr, Vallari AS, Justman J, Hodder S.

Use of a multifaceted approach to analyze HIV incidence in a cohort study of women in the United States: HIV Prevention Trials Network 064 Study.

J Infect Dis, 2013; 207(2): 223-31. 10.1093/infdis/jis658
Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH.

HIV incidence determination in the United States: a multiassay approach.

J Infect Dis, 2013; 207(2): 232-9. 10.1093/infdis/jis659
Brookmeyer R, Konikoff J, Laeyendecker O, Eshleman SH.

Estimation of HIV incidence using multiple biomarkers.

Am J Epidemiol, 2013; 77(3): 264-72. 10.1093/aje/kws436
Wendel SK, Mullis CE, Eshleman SH, Blankson JN, Moore RD, Keruly JC, Brookmeyer R, Quinn TC, Laeyendecker O.

Effect of natural and ARV-induced viral suppression and viral breakthrough on anti-HIV antibody proportion and avidity in patients with HIV-1 subtype B infection.

PLoS One, 2013; 8(2): e55525. 10.1371/journal.pone.0055525
James MM, Laeyendecker O, Sun J, Hoover DR, Mullis CE, Cousins MM, Coates T, Moore RD, Kelen GD, Fowler MG, Kumwenda JJ, Mofenson LM, Kumwenda NI, Taha TE, Eshleman SH.

Antibody maturation and viral diversification in HIV-infected women.

PLoS One, 2013; 8(2): e57350. 10.1371/journal.pone.0057350
Mullis CE, Munshaw S, Grabowski MK, Eshleman SH, Serwadda D, Brookmeyer R, Nalugoda F, Kigozi G, Kagaayi J, Tobian AA, Wawer M, Gray RH, Quinn TC, Laeyendecker O.

Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.

AIDS Res Hum Retroviruses, 2013; 29(8): 1146-50. 10.1089/AID.2012.0105
Laeyendecker O, Piwowar-Manning E, Fiamma A, Kulich M, Donnell D, Bassuk D, Mullis CE, Chin C, Swanson P, Hackett J Jr, Clarke W, Marzinke M, Szekeres G, Gray G, Richter L, Alexandre MW, Chariyalertsak S, Chingono A, Celentano DD, Morin SF, Sweat M, Coates T, Eshleman SH.

Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043).

PLoS One, 2013; 8(7): e68349. 10.1371/journal.pone.0068349
Brookmeyer R, Laeyendecker O, Donnell D, Eshleman SH.

Cross-sectional HIV incidence estimation in HIV prevention research.

J Acquir Immune Defic Syndr, 2013; 63 Supplement 2: S233-9. 10.1097/QAI.0b013e3182986fdf
Curtis KA, Longosz AF, Kennedy MS, Keating S, Heitman J, Laeyendecker O, Owen SM.

Inter-laboratory assessment of a prototype multiplex kit for determination of recent HIV-1 infection.

PLoS One, 2013; 8(10): 77765. 10.1371/journal.pone.0077765
Laeyendecker O, Kulich M, Donnell D, Komárek A, Omelka M, Mullis CE, Szekeres G, Piwowar-Manning E, Fiamma A, Gray RH, Lutalo T, Morrison CS, Salata RA, Chipato T, Celum C, Kahle EM, Taha TE, Kumwenda NI, Karim QA, Naranbhai V, Lingappa JR, Sweat MD, Coates T, Eshleman SH.

Development of methods for cross-sectional HIV incidence estimation in a large, community randomized trial.

PLoS One, 2013; 8(11): e78818. 10.1371/journal.pone.0078818
Konikoff J, Brookmeyer R, Longosz AF, Cousins MM, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Moore RD, Mehta SH, Margolick JB, Brown J, Mayer KH, Koblin BA, Justman JE, Hodder SL, Quinn TC, Eshleman SH, Laeyendecker O.

Performance of a limiting-antigen avidity enzyme immunoassay for cross-sectional estimation of HIV incidence in the United States.

PLoS One, 2013; 8(12): e82772. 10.1371/journal.pone.0082772
Ng KY, Chew KK, Kaur P, Kwan JY, Khong WX, Lin L, Chua A, Tan MT, Quinn TC, Laeyendecker O, Leo YS, Ng OT.

High prevalence of CXCR4 usage among treatment-naive CRF01_AE and CRF51_01B-infected HIV-1 subjects in Singapore.

BMC Infect Dis, 2013; 13: 90. 10.1186/1471-2334-13-90
Ng KT, Ng KY, Khong WX, Chew KK, Singh PK, Yap JK, Tan MT, Leo YS, Laeyendecker O, Quinn TC, Kamarulzaman A, Tee KK, Ng OT.

Phylodynamic profile of HIV-1 subtype B, CRF01_AE and the recently emerging CRF51_01B among men who have sex with men (MSM) in Singapore.

PLoS One, 2013; 8(12): e80884. 10.1371/journal.pone.0080884
Pena-Cruz V, Etemad B, Chatziandreou N, Nyein PH, Stock S, Reynolds SJ, Laeyendecker O, Gray RH, Serwadda D, Lee SJ, Quinn TC, Sagar M.

HIV-1 envelope replication and α4β7 utilization among newly infected subjects and their corresponding heterosexual partners.

Retrovirology, 2013; 10: 162. 10.1186/1742-4690-10-162
Shirreff G, Alizon S, Cori A, Günthard HF, Laeyendecker O, van Sighem A, Bezemer D, Fraser C.

How effectively can HIV phylogenies be used to measure heritability?

Evol Med Public Health, 2013; 1: 209-224. 10.1093/emph/eot019
Shardell M, Reich NG, Perencevich EN.

Commentary: Back to the future with Sir Bradford Hill: statistical analysis with hospital-acquired infections.

Int J Epidemiol, 2013; 42(5): 1509-1510. 10.1093/ije/dyt166
Lessler J, Metcalf CJ.

Balancing evidence and uncertainty when considering rubella vaccine introduction.

PLoS One, 2013; 8: e67639. 10.1371/journal.pone.0067639
Cutts FT, Lessler J, Metcalf CJ.

Measles elimination: progress, challenges and implications for rubella control.

Expert Rev Vaccines, 2013; 12: 917-32. 10.1586/14760584.2013.814847
Tobian AA, Grabowski MK, Serwadda D, Newell K, Ssebbowa P, Franco V, Nalugoda F, Wawer MJ, Gray RH, Quinn TC, Reynolds SJ; Rakai Health Sciences Program.

Reactivation of herpes simplex virus type 2 after initiation of antiretroviral therapy.

J Infect Dis, 2013; 208: 839-46. 10.1093/infdis/jit252
Tobian AA, Grabowski MK, Kigozi G, Gravitt PE, Eaton KP, Serwadda D, Nalugoda F, Wawer MJ, Quinn TC, Gray RH.

High-risk human papillomavirus prevalence is associated with HIV infection among heterosexual men in Rakai, Uganda.

Sex Transm Infect, 2013; 89: 122-7. 10.1136/sextrans-2012-050524
Redd AD, Wendel SK, Grabowski MK, Ocama P, Kiggundu V, Bbosa F, Boaz I, Balagopal A, Reynolds SJ, Gray RH, Serwadda D, Kirk GD, Quinn TC, Stabinski L.

Liver stiffness is associated with monocyte activation in HIV-infected Ugandans without viral hepatitis.

AIDS Res Hum Retroviruses, 2013; 29: 1026-30. 10.1089/AID.2013.0004
Tobian AA, Grabowski MK, Kigozi G, Redd AD, Eaton KP, Serwadda D, Cornish TC, Nalugoda F, Watya S, Buwembo D, Nkale J, Wawer MJ, Quinn TC, Gray RH.

Human papillomavirus clearance among males is associated with HIV acquisition and increased dendritic cell density in the foreskin.

J Infect Dis, 2013; 207: 1713-22. 10.1093/infdis/jit035
Davis MA, Gray RH, Grabowski MK, Serwadda D, Kigozi G, Gravitt PE, Nalugoda F, Watya S, Wawer MJ, Quinn TC, Tobian AA.

Male circumcision decreases high-risk human papillomavirus viral load in female partners: a randomized trial in Rakai, Uganda.

Int J Cancer, 2013; 133: 1247-52. 10.1002/ijc.28100
Sun AY, Pai M, Salje H, Satyanarayana S, Deo S, Dowdy DW.

Modeling the impact of alternative strategies for rapid molecular diagnosis of tuberculosis in Southeast Asia.

Am J Epidemiol, 2013; 178: 1740-9. 10.1093/aje/kwt210
Dowdy DW, Lotia I, Azman AS, Creswell J, Sahu S, Khan AJ.

Population-level impact of active tuberculosis case finding in an Asian megacity.

PLoS One, 2013; 8: e77517. 10.1371/journal.pone.0077517
Mullis CE, Munshaw S, Grabowski MK, Eshleman SH, Serwadda D, Brookmeyer R, Nalugoda F, Kigozi G, Kagaayi J, Tobian AA, Wawer M, Gray RH, Quinn TC, Laeyendecker O.

Differential specificity of HIV incidence assays in HIV subtypes A and D-infected individuals from Rakai, Uganda.

AIDS Res Hum Retroviruses, 2013; 29: 1146-50. 10.1089/AID.2012.0105
Gurley ES, Salje H, Homaira N, Ram PK, Haque R, Petri WA Jr, Bresee J, Moss WJ, Luby SP, Breysse P, Azziz-Baumgartner E.

Seasonal concentrations and determinants of indoor particulate matter in a low-income community in Dhaka, Bangladesh.

Environ Res, 2013; 121: 11-6. 10.1016/j.envres.2012.10.004
Gurley ES, Homaira N, Salje H, Ram PK, Haque R, Petri W, Bresee J, Moss WJ, Breysse P, Luby SP, Azziz-Baumgartner E.

Indoor exposure to particulate matter and the incidence of acute lower respiratory infections among children: a birth cohort study in urban Bangladesh.

Indoor Air, 2013; 23: 379-86. 10.1111/ina.12038
Kamuliwo M, Chanda E, Haque U, Mwanza-Ingwe M, Sikaala C, Katebe-Sakala C, Mukonka VM, Norris DE, Smith DL, Glass GE, Moss WJ.

The changing burden of malaria and association with vector control interventions in Zambia using district-level surveillance data, 2006-2011.

Malar J, 2013; 12: 437. 10.1186/1475-2875-12-437
McFall AM, Dowdy DW, Zelaya CE, Murphy K, Wilson TE, Young MA, Gandhi M, Cohen MH, Golub ET, Althoff KN; Women's Interagency HIV Study.

Understanding the disparity: predictors of virologic failure in women using highly active antiretroviral therapy vary by race and/or ethnicity.

J Acquir Immune Defic Syndr, 2013; 64: 289-98. 10.1097/QAI.0b013e3182a095e9
Azman AS, Rudolph KE, Cummings DA, Lessler J.

The incubation period of cholera: a systematic review.

J Infect, 2013; 66: 432-8. 10.1016/j.jinf.2012.11.013
Reiner RC Jr, Perkins TA, Barker CM, Niu T, Chaves LF, Ellis AM, George DB, Le Menach A, Pulliam JR, Bisanzio D, Buckee C, Chiyaka C, Cummings DA, Garcia AJ, Gatton ML, Gething PW, Hartley DM, Johnston G, Klein EY, Michael E, Lindsay SW, Lloyd AL, et al.

A systematic review of mathematical models of mosquito-borne pathogen transmission: 1970-2010.

J R Soc Interface, 2013; 10: 20120921. 10.1098/rsif.2012.0921
Mier-y-Teran-Romero L, Schwartz IB, Cummings DA.

Breaking the symmetry: immune enhancement increases persistence of dengue viruses in the presence of asymmetric transmission rates.

J Theor Biol, 2013; 332: 203-10. 10.1016/j.jtbi.2013.04.036
Meltzer AC, Pierce R, Cummings DA, Pines JM, May L, Smith MA, Marcotte J, McCarthy ML.

Rapid 13C Urea Breath Test to Identify Helicobacter pylori Infection in Emergency Department Patients with Upper Abdominal Pain.

West J Emerg Med, 2013; 14: 278-82. 10.5811/westjem.2012.12.15173
Blackwood JC, Cummings DA, Broutin H, Iamsirithaworn S, Rohani P.

Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand.

Proc Natl Acad Sci U S A, 2013; 110: 9595-600. 10.1073/pnas.1220908110
Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, Alabdullatif ZN, Assad M, Almulhim A, Makhdoom H, Madani H, Alhakeem R, Al-Tawfiq JA, Cotten M, Watson SJ, Kellam P, Zumla AI, Memish ZA; KSA MERS-CoV Investigation Team.

Hospital outbreak of Middle East respiratory syndrome coronavirus.

N Engl J Med, 2013; 369: 407-16. 10.1056/NEJMoa1306742
Reich NG, Shrestha S, King AA, Rohani P, Lessler J, Kalayanarooj S, Yoon IK, Gibbons RV, Burke DS, Cummings DA.

Interactions between serotypes of dengue highlight epidemiological impact of cross-immunity.

J R Soc Interface, 2013; 10: 20130414. 10.1098/rsif.2013.0414
Liu SH, Brotman RM, Zenilman JM, Gravitt PE, Cummings DA.

Menstrual cycle and detectable human papillomavirus in reproductive-age women: a time series study.

J Infect Dis, 2013; 208: 1404-15. 10.1093/infdis/jit337
Rodriguez-Barraquer I, Mier-y-Teran-Romero L, Burke DS, Cummings DA.

Challenges in the interpretation of dengue vaccine trial results.

PLoS Negl Trop Dis, 2013; 7: e2126. 10.1371/journal.pntd.0002126

Pages